KRW159,600.00
0.37% yesterday
Korea, Jun 27, 08:09 am CET
ISIN
KR7068270008
Symbol
068270
Index
Sector
Industry

Celltrion Stock price

KRW159,900.00
+10,284.61 6.87% 1M
-13,561.53 7.82% 6M
-20,388.47 11.31% YTD
+1,423.16 0.90% 1Y
+6,787.10 4.43% 3Y
-99,931.69 38.46% 5Y
+104,317.50 187.68% 10Y
+154,261.08 2,735.65% 20Y
Korea, Closing price Fri, Jun 27 2025
-300.00 0.19%
ISIN
KR7068270008
Symbol
068270
Index
Sector
Industry

Key metrics

Basic
Market capitalization
KRW36.6t
Enterprise Value
-
Net debt
-
Cash
-
Shares outstanding
Valuation (TTM | estimate)
P/E
67.15 | 37.77
P/S
9.98 | 8.13
EV/Sales
- | -
EV/FCF
-
P/B
-
Dividends
DPS
KRW721.15
Yield 1Y | 5Y
0.45% | 0.25%
Growth 1Y | 5Y
57.50% | -
Payout 1Y | 3Y
20.98% | 14.11%
Increased
2 Years
Financials (TTM | estimate)
Revenue
KRW3.7t | KRW4.5t
EBITDA
KRW744.7b | KRW1.6t
EBIT
KRW626.0b
Net Income
KRW508.9b | -
Free Cash Flow
KRW662.0b
Growth (TTM | estimate)
Revenue
58.14% | 26.38%
EBITDA
31.91% | 136.77%
EBIT
30.61%
Net Income
29.55% | -
Free Cash Flow
939.68%
Margin (TTM | estimate)
Gross
49.64%
EBITDA
20.34% | 35.43%
EBIT
17.09%
Net
13.90% | -
Free Cash Flow
18.08%
Financial Health
Equity Ratio
82.83%
Return on Equity
2.42%
ROCE
-
ROIC
-
Debt/Equity
-
More
EPS
KRW2,381.36
FCF per Share
Short interest
-
Employees
-
Rev per Employee
-
Show more

Is Celltrion a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,914 stocks worldwide.

Celltrion Stock Analysis

Unlock Scores for Free

Analyst Opinions

28 Analysts have issued a Celltrion forecast:

24x Buy
86%
3x Hold
11%
1x Sell
4%

Analyst Opinions

28 Analysts have issued a Celltrion forecast:

Buy
86%
Hold
11%
Sell
4%

Financial data from Celltrion

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Mar '25
+/-
%
3,662,235 3,662,235
58% 58%
100%
- Direct Costs 1,844,319 1,844,319
51% 51%
50%
1,817,916 1,817,916
66% 66%
50%
- Selling and Administrative Expenses 1,073,178 1,073,178
105% 105%
29%
- Research and Development Expense - -
-
-
744,738 744,738
32% 32%
20%
- Depreciation and Amortization 118,739 118,739
39% 39%
3%
EBIT (Operating Income) EBIT 625,999 625,999
31% 31%
17%
Net Profit 508,918 508,918
30% 30%
14%

In millions KRW.

Don't miss a Thing! We will send you all news about Celltrion directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Company Profile

Celltrion, Inc. engages in the development, manufacture and distribution of pharmaceuticals. It operates through the Biopharmaceuticals, Chemical Drugs and Others businesses. Its products include remsima and biosimilars. The company was founded on February 27, 1991 and is headquartered in Incheon, South Korea.

Head office South Korea
CEO Wu-Sung Ki
Founded 1991
Website www.celltrion.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today